CEO Marco Taglietti (Scynexis)
'Never been more urgent:' Scynexis looks to tackle superbug crisis with late-stage readout for antifungal hopeful
As the superbug crisis heats up around the world, Scynexis says it has new data from two interim analyses that prove its antifungal has the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
